Literature DB >> 2567032

Yawning and suppression of exploration in amphetamine-treated rats, incompatibility with the autoreceptor hypothesis.

L Ståhle1, U Ungerstedt.   

Abstract

The hypothesis that yawning and suppression of exploration, induced by low doses of dopamine agonists, are mediated by stimulation of dopamine autoreceptors was tested by studying the influence of amphetamine on these behavioural models and on extracellular levels of dopamine sampled by microdialysis. Behaviour was measured in a holeboard apparatus. A low dose of amphetamine (0.2 mg/kg) caused slight activation of habituated rats. The same dose of amphetamine completely counteracted the decrease in extracellular dopamine levels caused by pergolide (0.02 mg/kg) and, instead, elevated the dopamine levels to 300% above baseline. The same or higher doses of amphetamine (0.5-1.0 mg/kg) did not completely antagonise suppression of exploration or yawning induced by apomorphine (0.05 mg/kg) or pergolide (0.02 mg/kg). The results suggest that both yawning and suppression of exploration induced by low doses of dopamine agonists are not mediated by dopamine autoreceptors, since these behaviours could be elicited when the extracellular levels of dopamine were elevated above baseline. The alternative hypothesis that these behaviours are mediated by sensitive post-synaptic receptors is suggested. It was also found that combined treatment with SCH 23390 (0.05 mg/kg) and amphetamine (2 mg/kg) induced yawning, which further supports the new hypothesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567032     DOI: 10.1007/BF00439563

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Drugs affecting dopamine neurons and yawning behavior.

Authors:  E Mogilnicka; V Klimek
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

2.  Antagonism of apomorphine-induced yawning by SCH 23390: evidence against the autoreceptor hypothesis.

Authors:  M Morelli; R Longoni; L Spina; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

Authors:  K Starke; W Reimann; A Zumstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

4.  Automatic registration of behaviour related to dopamine and noradrenaline transmission.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

Review 5.  Effect of apomorphine on schizophrenic symptoms.

Authors:  R C Smith; C Tamminga; J M Davis
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

6.  Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

7.  Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

Authors:  J Lehmann; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

8.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.

Authors:  U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

10.  Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors.

Authors:  L Ståhle; U Ungerstedt
Journal:  Pharmacol Biochem Behav       Date:  1986-08       Impact factor: 3.533

View more
  7 in total

1.  Effects of low, autoreceptor selective doses of dopamine agonists on the discriminative cue and locomotor hyperactivity produced by d-amphetamine.

Authors:  L Furmidge; Z Y Tong; N Petry; D Clark
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants.

Authors:  M P Paulus; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study.

Authors:  L Ståhle; A K Collin; U Ungerstedt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

4.  Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.

Authors:  B A Mattingly; J K Rowlett; G Lovell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.

Authors:  W Kropf; K Kuschinsky; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

6.  Effects of single and repeated treatment with antidepressants on apomorphine-induced yawning in the rat: the implication of alpha-1 adrenergic mechanisms in the D-2 receptor function.

Authors:  A Delini-Stula; C Hunn
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.

Authors:  K Yamada; M Nagashima; H Kimura; S Matsumoto; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.